With obesity on the rise in the UK, more people are seeking medical weight loss support. Wegovy (semaglutide) and the upcoming Retatrutide offer promising, science-backed solutions — but how do you actually get them?
NHS Eligibility for GLP-1 Medications
You may qualify for Wegovy or Ozempic via the NHS if you meet the following criteria:
- BMI over 35 with obesity-related conditions (e.g., diabetes, sleep apnea)
- OR BMI over 30 and considered high-risk
- Have already tried lifestyle interventions (diet + exercise)
Private Prescription Options in the UK
If you don’t meet NHS guidelines, private clinics are an alternative. Many UK-based platforms now offer:
- Online consultation
- Medication delivery (Wegovy, Mounjaro)
- Monthly support & tracking
Prices range from £180–£350/month depending on dosage and provider.
How to Get Retatrutide (2025 Update)
Retatrutide is currently in trials and expected to be available in the UK by late 2025 or early 2026. Patients may join pre-approval access programs or ask their private provider to notify them when it’s launched.
Suggested Provider: GLPJourney.co.uk
What to Ask Your Doctor
Be prepared to discuss:
- Your BMI and health conditions
- Previous weight loss attempts
- Willingness to follow diet & coaching support
📎 Useful Internal Resource
Learn how GLP-1 injections work: Read Full Guide